Le Lézard
Classified in: Health, Business
Subject: CXP

Monte Nido & Affiliates Opens Residential Eating Disorder Program for All Genders in Chicago, IL on March 2, 2020


CHICAGO, March 2, 2020 /PRNewswire/ -- Monte Nido & Affiliates - the nation's leading provider of eating disorder treatment for over twenty-four years - announces the opening of Monte Nido Chicago on March 2, 2020 in Winfield, IL. In the comfort of a home, this residential treatment center provides programming for adults of all genders for the treatment of anorexia nervosa, bulimia nervosa, binge eating disorder and exercise dependency, as well as co-occurring substance use, trauma and psychiatric presentations. Monte Nido Chicago will be Monte Nido & Affiliates' first program in the state of Illinois and third residential treatment center nationwide to provide services to all genders upon opening. 

"Our programs are designed around the belief in a person's ability to become fully recovered," said Candy Henderson, MS, Monte Nido & Affiliates Chief Executive Officer. "We specialize in delivering evidence-based treatment backed by decades of providing successful healing and recovery for our clients nationwide." The program's treatment approach focuses on the restoration of physiological and nutritional balance, the implementation of mindful eating and exercise routines, the elimination of destructive behaviors and the development of motivation and treatment engagement. "Eating disorders do not discriminate, and we are proud to provide adults of all genders treatment in the Chicagoland area, allowing them to remain closer to home and their families," said Joel Jahraus, MD, CEDS, FAED, Chief Medical Officer of Monte Nido & Affiliates.

About Monte Nido & Affiliates
Monte Nido & Affiliates is the country's leading eating disorder treatment provider, offering residential and day treatment programs for eating disorders. Founded in 1996, Monte Nido & Affiliates operates twenty-four facilities in nine states, with all residential programs being Joint Commission accredited. Designed for all genders, Monte Nido & Affiliates includes three distinct eating disorder treatment brands: Monte Nido, Oliver-Pyatt Centers and Clementine. To inquire about treatment at one of Monte Nido & Affiliates programs, please contact us below:

Monte Nido: 888.228.1253, www.montenido.com
Clementine: 855.900.2221, www.clementineprograms.com
Oliver-Pyatt Centers, 866.511.4325, www.oliverpyattcenters.com

Contact: Claire Vartabedian or Abigail Cox
L.C. Williams & Associates
312-565-3900
[email protected] or [email protected]

 

SOURCE Monte Nido


These press releases may also interest you

at 15:23
Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to...

at 15:20
One of the main roles of the spleen is to help the body's immune system fight infections. The spleen does this through producing and regulating antibodies ? antibody production is negatively affected in various conditions, including sepsis and...

at 15:02
Prominently featured in The Inner Circle, Lee C. Ferguson, DO, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Vascular Surgeon. Dr. Ferguson, a distinguished dual board-certified vascular surgeon and endovascular...

at 15:00
The Honourable David J. McGuinty, Member of Parliament for Ottawa South,  on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care. MP McGuinty will be available to...

at 14:43
Sugar Kayne Radio, an innovative internet radio station founded by Matthew Kayne, also known as DJ Sugar Kayne, is set to launch on 2nd June. Located in the heart of North West London, Sugar Kayne Radio aims to revolutionize the online music...

at 14:38
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars," by Sarah Yim,...



News published on and distributed by: